LINC00963 Represses Osteogenic Differentiation of hBMSCs via the miR-10b-5p/RAP2A/AKT Axis

Abstract

Osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) is important for human bone formation. Long non-coding RNAs (lncRNAs) are critical regulators in osteogenic differentiation. This study aimed to explore the function and mechanisms of long intergenic non-protein coding RNA 963 (LINC00963) in affecting osteogenesis. Cell differentiation was assessed by alkaline phosphatase (ALP) activity detection and ALP staining assay. Meanwhile, levels of osteogenic marker genes, including RUNX family transcription factor 2 (RUNX2), osteocalcin (OCN), and osteopontin (OPN), were detected by RT-qPCR and western blot. Cell proliferation and apoptosis were measured using CCK-8 assay and flow cytometry analysis. RNA immunoprecipitation (RIP), RNA pull-down and luciferase reporter assays were used to investigate the interaction between genes. LINC00963 expression was down-regulated in hBMSCs treated with osteogenic induction. LINC00963 overexpression inhibited hBMSCs differentiation, proliferation, and elevated apoptosis. LINC00963 acted as a competing endogenous RNA (ceRNA) to interact with miR-10b-5p and thereby regulated the expression level of Ras-related protein Rap-2a (RAP2A). LINC00963 regulated RAP2A to inhibit the level of phosphorylated AKT (p-AKT). LINC00963 inhibited hBMSCs differentiation, proliferation, and elevated apoptosis via the miR-10b-5p/RAP2A/AKT signaling, which might help improve the treatment of osteoporosis.

Keywords

postmenopausal osteoporosis - LINC00963 - differentiation - AKT

Publication History

Received: 22 August 2022

Accepted: 26 April 2024

Article published online:
28 July 2024

• References

• 1 Armas LA, Recker RR. Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin North Am 2012; 41: 475-486 DOI: 10.1016/j.ecl.2012.04.006.
• 2 Jackson RD, Mysiw WJ. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative. Semin Reprod Med 2014; 32: 454-462 DOI: 10.1055/s-0034-1384629.
• 3 Vilaca T, Eastell R, Schini M. Osteoporosis in men. Lancet Diabetes Endocrinol 2022; 10: 273-283 DOI: 10.1016/s2213-8587(22)00012-2.
• 4 Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006; 17: 1726-1733 DOI: 10.1007/s00198–006-0172-4.
• 5 Shepstone L, Lenaghan E, Cooper C. et al. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 2018; 391: 741-747 DOI: 10.1016/s0140-6736(17)32640-5.
• 6 De Souza MJ, Koltun KJ, Williams NI. The Role of Energy Availability in Reproductive Function in the Female Athlete Triad and Extension of its Effects to Men: An Initial Working Model of a Similar Syndrome in Male Athletes. Sports Med 2019; 49: 125-137 DOI: 10.1007/s40279-019-01217-3.
• 7 Nattiv A, De Souza MJ, Koltun KJ. et al. The Male Athlete Triad–A Consensus Statement From the Female and Male Athlete Triad Coalition Part 1: Definition and Scientific Basis. Clin J Sport Med 2021; 31: 345-353 DOI: 10.1097/jsm.0000000000000946.
• 8 Tenforde AS, Carlson JL, Sainani KL. et al. Sport and triad risk factors influence bone mineral density in collegiate athletes. Med Sci Sports Exerc 2018; 50: 2536-2543 DOI: 10.1249/mss.0000000000001711.
• 9 Scofield KL, Hecht S. Bone health in endurance athletes: runners, cyclists, and swimmers. Curr Sports Med Rep 2012; 11: 328-334 DOI: 10.1249/JSR.0b013e3182779193.
• 10 Sale C, Elliott-Sale KJ. Nutrition and athlete bone health. Sports Med 2019; 49: 139-151 DOI: 10.1007/s40279-019-01161-2.
• 11 Samsonraj RM, Paradise CR, Dudakovic A. et al. Validation of osteogenic properties of cytochalasin D by high-resolution RNA-sequencing in mesenchymal stem cells derived from bone marrow and adipose tissues. Stem Cells Dev 2018; 27: 1136-1145 DOI: 10.1089/scd.2018.0037.
• 12 Huang Y, Yin Y, Gu Y. et al. Characterization and immunogenicity of bone marrow-derived mesenchymal stem cells under osteoporotic conditions. Sci China Life Sci 2020; 63: 429-442 DOI: 10.1007/s11427-019-1555-9.
• 13 Huang S, Zhu X, Xiao D. et al. LncRNA SNHG1 was down-regulated after menopause and participates in postmenopausal osteoporosis. Biosci Rep 2019; 39 DOI: 10.1042/bsr20190445.
• 14 Xiaoling G, Shuaibin L, Kailu L. MicroRNA-19b-3p promotes cell proliferation and osteogenic differentiation of BMSCs by interacting with lncRNA H19. BMC Med Genet 2020; 21: 11 DOI: 10.1186/s12881-020-0948-y.
• 15 Jiao H, Jiang S, Wang H. et al. Upregulation of LINC00963 facilitates melanoma progression through miR-608/NACC1 pathway and predicts poor prognosis. Biochem Biophys Res Commun 2018; 504: 34-39 DOI: 10.1016/j.bbrc.2018.08.115.
• 16 Xie LB, Chen B, Liao X. et al. LINC00963 targeting miR-128-3p promotes acute kidney injury process by activating JAK2/STAT1 pathway. J Cell Mol Med 2020; 24: 5555-5564 DOI: 10.1111/jcmm.15211.
• 17 Fei Q, Bai X, Lin J. et al. Identification of aberrantly expressed long non-coding RNAs in postmenopausal osteoporosis. Int J Mol Med 2018; 41: 3537-3550 DOI: 10.3892/ijmm.2018.3575.
• 18 Ren L, Guo L, Kou N. et al. LncRNA LINC00963 promotes osteogenic differentiation of hBMSCs and alleviates osteoporosis progression by targeting miRNA-760/ETS1 axis. Autoimmunity 2021; 54: 313-325 DOI: 10.1080/08916934.2021.1922890.
• 19 Zhang H, Bian C, Tu S. et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in human aortic dissection. BMC Genomics 2021; 22: 724 DOI: 10.1186/s12864-021-08012-3.
• 20 Mahesh G, Biswas R. MicroRNA-155: A master regulator of inflammation. J Interferon Cytokine Res 2019; 39: 321-330 DOI: 10.1089/jir.2018.0155.
• 21 Li Z, Zhang W, Huang Y. MiRNA-133a is involved in the regulation of postmenopausal osteoporosis through promoting osteoclast differentiation. Acta Biochim Biophys Sin (Shanghai) 2018; 50: 273-280 DOI: 10.1093/abbs/gmy006.
• 22 Fu Y, Xu Y, Chen S. et al. MiR-151a-3p promotes postmenopausal osteoporosis by targeting SOCS5 and activating JAK2/STAT3 signaling. Rejuvenation Res 2020; 23: 313-323 DOI: 10.1089/rej.2019.2239.
• 23 Singh R, Ha SE, Wei L. et al. miR-10b-5p rescues diabetes and gastrointestinal dysmotility. Gastroenterology 2021; 160: 1662-1678.e1618 DOI: 10.1053/j.gastro.2020.12.062.
• 24 Wu L, Chen Y, Chen Y. et al. Effect of HIF-1α/miR-10b-5p/PTEN on hypoxia-induced cardiomyocyte apoptosis. J Am Heart Assoc 2019; 8: e011948 DOI: 10.1161/jaha.119.011948.
• 25 Quan R, Liang W, Li H. et al. Silencing of miR-10b-5p alleviates the mechanical stretch-induced proliferation of HASMCs. Tissue Cell 2022; 74: 101700 DOI: 10.1016/j.tice.2021.101700.
• 26 Wang M, Li J, Ye Y. et al. SHED-derived conditioned exosomes enhance the osteogenic differentiation of PDLSCs via Wnt and BMP signaling in vitro. Differentiation 2020; 111: 1-11 DOI: 10.1016/j.diff.2019.10.003.
• 27 Carlevaro-Fita J, Johnson R. Global positioning system: Understanding long noncoding RNAs through subcellular localization. Mol Cell 2019; 73: 869-883 DOI: 10.1016/j.molcel.2019.02.008.
• 28 Turchinovich A, Weiz L, Langheinz A. et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011; 39: 7223-7233 DOI: 10.1093/nar/gkr254.
• 29 Wang L, Zhan W, Xie S. et al. Over-expression of Rap2a inhibits glioma migration and invasion by down-regulating p-AKT. Cell Biol Int 2014; 38: 326-334 DOI: 10.1002/cbin.10213.
• 30 Sun Y, Wang TE, Hu Q. et al. Systematic comparation of the biological and transcriptomic landscapes of human amniotic mesenchymal stem cells under serum-containing and serum-free conditions. Stem Cell Res Ther 2022; 13: 490 DOI: 10.1186/s13287-022-03179-2.
• 31 Ko NY, Chen LR, Chen KH. The role of micro RNA and long-non-coding RNA in osteoporosis. Int J Mol Sci 2020; 21 DOI: 10.3390/ijms21144886.
• 32 Yuan Y, Guo J, Zhang L. et al. MiR-214 Attenuates the osteogenic effects of mechanical loading on osteoblasts. Int J Sports Med 2019; 40: 931-940 DOI: 10.1055/a-1015-0285.
• 33 Zhang N, Zeng X, Sun C. et al. LncRNA LINC00963 promotes tumorigenesis and radioresistance in breast cancer by sponging miR-324-3p and inducing ACK1 expression. Mol Ther Nucleic Acids 2019; 18: 871-881 DOI: 10.1016/j.omtn.2019.09.033.
• 34 Wu Z, Wang W, Wang Y. et al. Long noncoding RNA LINC00963 promotes breast cancer progression by functioning as a molecular sponge for microRNA-625 and thereby upregulating HMGA1. Cell Cycle 2020; 19: 610-624 DOI: 10.1080/15384101.2020.1728024.
• 35 Ge G, Yang D, Tan Y. et al. miR-10b-5p regulates C2C12 myoblasts proliferation and differentiation. Biosci Biotechnol Biochem 2019; 83: 291-299 DOI: 10.1080/09168451.2018.1533805.
• 36 Chen R, Liao X, Chen F. et al. Circulating microRNAs, miR-10b-5p, miR-328-3p, miR-100 and let-7, are associated with osteoblast differentiation in osteoporosis. Int J Clin Exp Pathol 2018; 11: 1383-1390
• 37 Li Y, Chen D, Li Y. et al. Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer. Oncol Rep 2016; 35: 1967-1978 DOI: 10.3892/or.2016.4579.
• 38 Zheng X, Zhao W, Ji P. et al. High expression of Rap2A is associated with poor prognosis of patients with hepatocellular carcinoma. Int J Clin Exp Pathol 2017; 10: 9607-9613
• 39 Pompura SL, Dominguez-Villar M. The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function. J Leukoc Biol 2018; DOI: 10.1002/jlb.2mir0817-349R.
• 40 Revathidevi S, Munirajan AK. Akt in cancer: Mediator and more. Semin Cancer Biol 2019; 59: 80-91 DOI: 10.1016/j.semcancer.2019.06.002.
• 41 Wu JX, Du WQ, Wang XC. et al. Rap2a serves as a potential prognostic indicator of renal cell carcinoma and promotes its migration and invasion through up-regulating p-Akt. Sci Rep 2017; 7: 6623 DOI: 10.1038/s41598-017-06162-7.
• 42 Wu JH, Tian XY, An QM. et al. LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway. Eur Rev Med Pharmacol Sci 2018; 22: 1645-1652 DOI: 10.26355/eurrev_201803_14574.